Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
Abstract Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation. Nevertheless, the risk of QT prolonga...
Guardado en:
Autores principales: | Byung Jin Choi, Yeryung Koo, Tae Young Kim, Wou Young Chung, Yun Jung Jung, Ji Eun Park, Hong-Seok Lim, Bumhee Park, Dukyong Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e76cb6ce35c44c5b3b7684233b37918 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.
por: Sundeep Singh Dhillon, et al.
Publicado: (2013) -
Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
por: Biswadeep Das, et al.
Publicado: (2021) -
Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
por: Farrell DF
Publicado: (2012) -
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
por: Juan Jiménez-Jáimez, et al.
Publicado: (2020) -
Prescribing errors involving antineoplastics and others drug centre of preparation of injectable drugs
por: Luciana SANTOS, et al.
Publicado: (2020)